ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "new ages"
new ages
Osoba
Předměty
Osoby
Publikace
Studium
MUDr. Michal Karas Ph.D.
Externí akademický pracovník na Ústřední knihovna
64 publikací
Publikace
publication
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter
2019 |
1. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové
publication
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
2019 |
Lékařská fakulta v Plzni
publication
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning
2019 |
Publikace bez příslušnosti k fakultě
publication
Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients
2018 |
Publikace bez příslušnosti k fakultě
publication
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation
2017 |
Publikace bez příslušnosti k fakultě
publication
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation
2017 |
Publikace bez příslušnosti k fakultě
publication
Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission
2016 |
1. lékařská fakulta, Lékařská fakulta v Plzni
publication
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
2016 |
Lékařská fakulta v Plzni
publication
Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia
2016 |
Lékařská fakulta v Plzni
publication
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: An analysis of 96 allografted AML patients >= 50 years from the Czech acute leukaemia clinical register (alert)
2013 |
Lékařská fakulta v Plzni, Ústřední knihovna, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
Načíst další publikace (54)
Loading network view...